NEW YORK — BioIVT said on Monday that it has acquired UK-based virtual biobank Tissue Solutions.
BioIVT said that it intends to continue operating Tissue Solutions' facilities. Financial terms of the deal were not disclosed.
Tissue Solutions provides a range of specimens through a global supplier network including fresh, frozen, and formalin-fixed, paraffin-embedded control tissue and skin samples; disease state peripheral blood mononuclear cells and bone marrow mononuclear cells; and fresh and frozen blood and biofluids.
Westbury, New York-based BioIVT markets research models and services for drug discovery and development, specializing in control and disease-state biospecimens such as human and animal tissues, cell products, blood, and other biofluids.
"This acquisition will add 150 collection sites to BioIVT's network, giving us greater access to high-quality control and disease state biospecimens and increased global reach for prospective collections," BioIVT CEO Jeff Gatz said in a statement. "Furthermore, it will expand our skin product offerings for in vitro models."